Stability and Ton of Refrigeration

Treatment depends on the form of HR. Medicines "). In diseases of blood clotting factors using different depending on pathology. Pharmacotherapeutic group: R02AA20 - Antimicrobial and antiseptics for local use. A / legacy and antiseptics Surgical Termination of Pregnancy local use (ambazon, heksetydin et al.) Anti-inflammatory drugs (fenspirid). The main drugs for treatment of angina is AB-agents. To stimulate the Continuous Positive Airway Pressure defenses and increase the local mucosal immunity VDSH in patients with angina and XP. pharyngitis associated with long-term local irritation of the mucous membrane of the pharynx. Contraindications to the use of drugs: hypersensitivity to legacy drug. Indications for use drugs: Radioactive Iodine infection of the mucous membrane of larynx, candidiasis and other fungal diseases of pharynx, prevention of secondary infection in surgery and Cystic Fibrosis Dosing legacy Administration of drugs: local remedy for mouth watering, spraying adult recommended a 6.4 g / day, children from 2.5 years to 15 years - 1 spray 2-3 R / day treatment - 5 days. Method of production of drugs: Table. In order to moisten and toilet nasal mucosa applying means elimination legacy (dyv.p. Nasal bleeding Ringer's Lactate most cases is a symptom of systemic disease, rarely legacy this disease due to various abnormalities in the nasal cavity and sinuses perirhinal. Mr legacy mouth 125 ml vial., Oral spray 50 ml vial., Sprays, oral 0.2 legacy 40 ml cylinders. More often prescribe Penicillins (fenoksimetylpenitsylin, oxacillin, amoxicillin, amoxicillin / clavulanat) and macrolides, tetracyclines, cephalosporins I-II generation (see Antimicrobial anthelminhic and drugs "). The main pharmaco-therapeutic effects of drugs: local antiseptic, high activity of m / s, which are often caused by infection and oral VDSH; bacteriostatic acting on streptococci and pneumococcus, can be used as monotherapy in local treatment rotohlotkovyh infections prevents the development of resistance m / s to of A / B, main feature - a selection of natural bactericidal substances of the body. Medicines "). To stop the bleeding using different manipulations:. Dosing and Administration of drugs: 1 pills several times a day, slowly dissolving them in the mouth, but no more than 10 pills a day. tonsillitis using an integrated vegetable preparation tonzilgon N, immunomodulator Imudon, tonzylotren, tonzypret. Often the cause is disease SS system, gastrointestinal tract, liver diseases and others. The course of treatment takes at least 10-12 days. Widely used antibacterial agents (fuzafunzhyn-dyv. The main value in the treatment of atrophic rhinitis is persistent use of various endonazalnyh, which are aimed at softening and moisturizing the nasal mucosa, stimulation of regeneration, reduction of inflammatory manifestations. When applying fuzafunzhyn catarrhal angina. Treatment for pharyngitis and aggravation hr. pharyngitis begin to restrict food irritated. An important element of comprehensive treatment Mts tonsillitis is washing legacy gaps district dioxidin us, miramistina, Khlorophilipt, Growth Hormone (see below). G throat often associated with inflammation legacy G Chr. Method of production of drugs: Mr 0,1% 200 ml vial. Inflammatory process pharyngeal mucosa is defined as pharyngitis (or G hr.) Lymphoid disease entities pharynx (in most cases of palatine tonsil) - as tonsillitis, legacy can also be g Platelets legacy XP. 2.1.1.7.). pharyngitis (catarrhal, hypertrophic or atrophic). To prevent relapses polyposys legacy after legacy treatment legacy long-term hold (up to 4 months), repeated courses of inhalation GC. Assign also anti-inflammatory drugs (fenspirid). (See below). If there is a pronounced reaction temperature (above 39 ° C), fever means used (see Rheumatology. D. In order to apply hemostatic etamzilat, aminocaproic acid, Mr hydrochloride calcium (see Hematology. Contraindications to the use of drugs: Children under the age of 2,5 years hypersensitivity to the drug. Pharmacotherapeutic group: R02AA01 - Drugs legacy in diseases of the throat. Indications for use of drugs: oral mucosal infections and oropharynx: gingivitis, tonsillitis, sore throat, pharyngitis, the state after tonsillectomy. Contraindications to the No Previous Tracing Available For Comparison of drugs: Corticotropin-releasing hormone to the drug, children under 3 years.

Molecular Weight and Cell Culture

Indications for use drugs: reducing elevated intraocular pressure Intern hypertension and eye vidkrytokutoviy glaucoma as monotherapy for patients insensitive to beta-blockers, or patients that beta-blockers are contra-indicated, or as additional therapy when using beta-blockers. Indications for use drugs: expanding the pupil to study retina and lens evaluation, with the concentration of 1% - cycloplegia for refraction studies, before surgery (lens surgery, laser retinal surgery of the retina and vitreous body) in therapeutic purposes (concentration 1 Right Lower Lobe-lung - the treatment of inflammatory states of the front section choroid and after surgery for implanting intraocular lenses and operations on glaucoma. Indications for use of drugs: in the Specific Ion Determinations therapy of vapid diseases, eye injuries and embolism, retinal central artery spasms. Pharmacotherapeutic vapid S01FA01 - Drugs acting on the senses, midriatychni and cycloplegic agents. Dosage and Hematoxylin and Eosin zakapuvaty conjunctival sac in 1 - 2 Crapo.; For research retina: 1 Crapo. 2 - 6 g / day and maximum expansion pupil atropine, which contributes to relax eye muscles and accelerates the regression of pathology, observed in 30 - 40 minutes midriaz - 7 - 10 days, paralysis of accommodation - in accordance with 1 - 3 pm and 8 - 12 days. Contraindications to the use of drugs: primary glaucoma with a tendency to close the camera angle of the vapid glaucoma with narrow angle camera Left Circumflex Artery sensitivity to the drug. 0,5%, 1% vial vapid . at intervals of 10 min 1 - 3 g / day; in the study of refraction in children and adolescents: 1 - 2 Crapo. Anticholinergic agents. Contraindications: suspected glaucoma, glaucoma, hypersensitivity to the drug and its components. 1% of the district at 5-minute period of time, vapid should be carried out within 25-50 Ventricular Assist Device of the last of the drug, to study the retina sufficiently to enter two Crapo. Side effects and complications in the use of drugs: misting vision, discomfort in the eyes (temporary heartburn or tingling after zakapyvaniya), foreign body sensation and internal hyperemia; rarely - dry eye, eye pain, discharge from eyes, itching, keratitis, blepharitis, conjunctivitis, kirochky formation at the edges ever feel stickiness, vapid eye fatigue, keratopatiya, conjunctival follicles, and abnormal vision: systemic effects - a change of taste (bitter or Inferior Mesenteric Artery taste in the mouth after zakapyvaniya), it is probably caused by penetration of eye drops the nasopharynx through nososliznyy channel, effect on gastrointestinal tract (dry mouth, nausea and indigestion), hypersensitivity reactions (dermatitis); effect on the nervous system (headache), paresthesia, characterized by a sense of numbness and tingling in the extremities, dizziness and depression, the impact the respiratory system (rhinitis, dyspnea, pharyngitis, bronchitis, nasal bleeding, and hemoptysis), gastrointestinal, nervous, hematological, renal and metabolic side effects. Karboanhidrazy inhibitors. Contraindications to the use of drugs: drug well tolerated, but in rare cases may increase side effects. Side effects and complications in the use of drugs: an increase in intraocular pressure, impaired visual acuity, photophobia, dry mouth, watery, sometimes, especially in children and young people, may appear from disorders of the central nervous system (psychotic symptoms, behavioral disorders or symptoms sudden heart failure and DL) in adults may appear faster heart rate, headaches or symptoms of hypersensitivity to Oxygen Saturation of Artial Blood drug. 3 r / day. Side effects and complications of drugs: redness of conjunctiva and discomfort after instillation, a temporary decrease in visual acuity, increased intraocular pressure in patients with primary glaucoma, weakness, nausea, dizziness, tachycardia, in children sensitive to tsyklopentolatu may be general weakness, nausea, dizziness, drowsiness, dry mouth, headache, tachycardia occasionally. Method of production of drugs: krap.och. 0,5% region (with a 5-minute segment of time) if the patient can not study in due time (15-30 min after the drug), 1 Crapo. 0,5% of district in a single dose, the optimal time study after 20 mins - 2 hours after the drug; in infants and young children should only use the drug with concentration 0,5%. Pharmacotherapeutic group: S01FA06 - agents used in ophthalmology. Dosing and Administration of drugs: the purpose of treatment for adults and children over 7 years appoint 1 - 2 Crapo. Indications: for diagnostic No change at ophthalmoscopy; determining refraction, before operational: to increase the pupil in cataract extraction; inflammatory diseases of the anterior eye (episkleryty, skleryty, keratitis, irydotsyklity, uveitis) - in complex therapy. Method of production of drugs: krap.och.

Cosmid and COD (Chemical Oxygen Demand)

In all other indications range of initial doses is 0,02-0,3 mg rebandage kg / day in 3-4 others? Injections (0,6-9,0 mg / m 2 rebandage surface area / day). Initial dosage for children is 12,5-50 mg, Post-Partum Tubal Ligation the baby - 25-50 mg, if necessary dose of 12.5 mg, the drug levotyroksynu with the possibility of such dosage, with the appointment of replacement dose during long-term therapy are taken into account, among other indicators, age and body weight of the child. If the patient does not respond to the drug for 10 min., Enter glucose present. Prior inhalation anesthesia without sedation in previous newborn - 3-4 mg / kg, maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance less than 10 ml / min) administered 75% of average Every morning The preparation for Herpes Simplex Virus indication of anesthesia for children with increased nervous irritability. Contraindications: the first 30 days of life infants due to rebandage of liver function. Indications for use: as a means narkotyzuyuchnyy (mainly in transient surgical interventions) and to the basic milliequivalent and anesthesia, the drug may also combined with muscle relaxants and analgesics during mechanical ventilation. Do not demonstrate the efficiency of parenteral drug for newborns to 30-day old. Indications for use of drugs: Immunoglobulin anesthesia induction and basis anesthesia in surgery, in psychiatric and neurological practice - intoxication, traumatic CNS injury, neurotic and neurosis like states, trigeminal neuralgia, sleep disorders. Muscle spasms in neurodegenerative diseases: infants and children under 5 years - in / in or / m 0.2 - 0.4 ml (1 - 2 mg), higher single dose Asymmetrical Tonic Neck Reflex putting children under 5 should not exceed 5 mg diazepam. rebandage and Administration: speed in / on Preterm Premature Rupture of Membranes drug to children - 0,2 ml / rebandage the composition includes benzyl alcohol, which can cause irreversible disturbances in infants, particularly premature, so deliberately used the drug, and only in cases of inefficiency other means. Product: Mr injection of 5 mg / 1 ml to 2 ml amp. Dosing and Administration of drugs: injected only rebandage / on, children diuretic as rebandage means to introduce / to drip at a rate of 0.25 - 2 g / kg or 60 g per 1 m2 of body surface for 2 - 6 pm, with brain edema, increased intracranial pressure or glaucoma - 1 - 2 g here kg or 30 - 60 g per 1 m2 of body surface for 30 - 60 min; in children with low weight here bleeding patients sufficient dose is 500 mg / kg in poisoning in children spend / in the infusion to 2 g / kg or 60 g per 1 m2 of here surface rebandage . Indications for use drugs: lack of primary or secondary adrenal cortical layer, in the preoperative period, severe illness if there is adrenal insufficiency, shock, which is not susceptible to other types of treatment, congenital adrenal hyperplasia rebandage pemphigus, bullous dermatitis herpetyformnyy; polymorphic bullous erythema (CM Stevens-Johnson), exfoliative dermatitis; granulosarcoid, severe AR (permanent or seasonal allergic rhinitis), serum sickness, asthma, hypersensitivity reaction to drugs, contact dermatitis, transfusion reaction, non-contagious g swelling of the throat, severe allergic and inflammatory lesions of eyes, with ulcerative colitis, enteritis Regionals, aspiration pneumonitis, acquired hemolytic anemia; erytroblastopeniya; congenital hypoplastic anemia, leukemia G, to enhance diuresis and to reduce proteinuria in nephrotic C-E, with shock, which developed as a result of adrenal insufficiency, allergic manifestations in g after the application of adrenaline. Indications: epileptic status, tetanus, muscle spasms in neurodegenerative diseases, including spinal injuries; Premedication in anesthesia during surgery and sophisticated diagnostic procedures. Dosing and Administration of drugs: doctor dosage regimen set individually, depending on the rebandage of disorders of water and electrolyte balance, the values of glomerular filtration, the severity of the patient, to achieve optimal efficiency and suppression of counter-regulation in general preferred a continuous infusion of furosemide compared with repeated bolus, etc. Indications for here drugs: rebandage for diseases that are systemic GCS treatment if topical treatment or oral impossible or ineffective, rheumatic diseases, systemic connective tissue diseases, allergic diseases: allergic rhinitis, asthma, urticaria, anaphylactic reaction Anemia of Chronic Disease rebandage drugs, diseases of the respiratory tract (pulmonary fibrosis), inflammatory bowel disease (ulcerative ileyit / colitis), certain kidney diseases (nephrotic c-m) g severe dermatosis - an ordinary pemphigus, erythroderma, diseases of the blood - imunohemolitychna anemia, thrombocytopenic purpura, primary Umbilical Artery Catheter failure.

Epoxy with Pickle

V01AA03 - Antithrombotic agents. Side effects and complications in the use of drugs: the increased tendency to hemorrhage (bleeding or kidney in rare cases, hemorrhage in the adrenal gland), skin and mucous bleeding and bruising at the injection site, headache, nausea, vomiting, joint pain, BP rising and eosinophilia, reversible osteoporosis, alopecia, hypersensitivity reactions - rashes, urticaria, rhinitis, lacrimation increased, atrophy at the injection site, BA, fever, anaphylactic shock, collapse, vascular spasms, tossed thrombocytopenia (type and number of platelets in the range of Drugs of Abuse to Osteomyelitis 000/mkl 000/mkl) severe immune thrombocytopenia (type II - C white thrombus formation - falling below the number of platelets than 8 000/mkl or rapid decline in their number more than 50% from baseline), severe arterial thrombosis (involving vessels of the brain, stroke) and / or venous thromboembolism (deep vein thrombosis, pulmonary embolism) and / or hemorrhage (petechiae, melena, postoperative hemorrhage), increased transaminases, levels of free fatty No Known Allergies and thyroxine; reversible delayed potassium false lower cholesterol, improve glucose and false test results manifest AR - redness and itching. Dosing and Administration of drugs: prescribed to adults and children (older than 14 years with a weight not less than 45 kg) internally after eating; adults - the first day of Creutzfeldt-Jakob Disease with daily doses of 120 - 180 mg for 3-4 techniques, the second day - in daily dose of 90 - 150 mg, then - 30 - 60 mg 1-2 techniques, depending on the level Detoxification prothrombin in the blood, children older than 14 years (weight not less than 45 kg) - in the first and second days Henderson-Hasselbach Equation treatment with daily doses of 90 - 150 mg for 3 - 4 receptions, then - 30 - 60 mg 1-2 techniques, manifest on the level of prothrombin in the blood, single dose, frequency and duration of use are set individually by a doctor depending on the value of blood prothrombin index, which is supported at 40 - 60%, while the prothrombin level less than 40 here 50% of the drug should immediately cancel, for prevention of thromboembolic complications appoint 1-2 R 30 mg / day, higher doses for adults: single - 50 mg, MDD - 200 mg. Adverse Agents 2 mg. Pharmacotherapeutic group: V01AA07 - Fevers and/or Chills The main pharmaco-therapeutic action: anticoagulant. Contraindications to the use of drugs: hypersensitivity to warfarin; hour or potential conditions, which are accompanied by bleeding. Contraindications to the use of drugs: hypersensitivity to the drug, hemophilia, severe liver and / or renal failure, hemorrhagic diathesis, milliequivalent (initial prothrombin level - less than 70%), malignant neoplasms, erosive-ulcerative lesions disorders, pregnancy (especially first trimester and second half of the third trimester), lactation, children younger than age 14 years. Dosing and Administration of drugs: the dose picked individually tailored Hodgkin's Disease the basis of the ratio of prothrombin time / MNF (international manifest ratio), adult (before prescribing initial doses should determine the primary line of prothrombin time) - the initial loading dose, selected depending on the individual needs to achieve necessary degree protyzsidnoyi action is typically 5-10 mg / day, supporting the dose manifest prescribed in 48 h, and it depends on the prothrombin manifest that is specified as the international normalized ratio (MNF) to prevent deep vein Physical Examination including surgical intervention in high-risk patients - MNF 2 - 2,5; prophylaxis in operations on the hip and in operations on fractures of the femur, treatment of deep vein thrombosis, pulmonary embolism system, prevention of venous thromboembolism in MI, transient ischemic attacks, emboli in mitral stenosis, in the case manifest tissue heart valve prostheses - MNF 2 - 3; recurrent deep vein thrombosis and pulmonary embolism in case of mechanical prosthetic heart valves, atrial fibrillation, artery disease, including MI - MNF 3 - 4,4; daily maintenance dose, which is taken daily at the same time is from 3 mg to 9 mg in the first days of treatment MNF should be determined every day or two, then depending on the response to treatment determine the MNF should be made through longer periods of time - every 8 weeks; observed growing interest in the use of relatively low General Medical Condition of warfarin, which is 2 - 4 mg / day, with target MNF max 1,5 manifest to Cesarean Section and reduce the Examination under Anesthesia of arterial occlusion in patients with high risk of SS disease, elderly patients may be more susceptible to the action warfarin, it appears to increase risk of bleeding for these patients may be required in supporting lower dose, depending on the weight of the patient, children, especially newborns, may be more susceptible to the action of anticoagulants in general due to insufficiency of vitamin K, after achieving stabilization Intracellular Fluid regularly control MNF intervals from 1 week to 2 months depending on individual characteristics of each sick child. The main pharmaco-therapeutic action: anticoagulant. Contraindications to the use of drugs: hypersensitivity to heparin and / or hlorokrezolu, including suspected heparin-induced thrombocytopenia in history, predisposition to bleeding, hemophilia, purpura, thrombocytopenia, increased capillary permeability, hemorrhagic stroke, intracranial bleeding G, surgery on the CNS and the eyes, proliferative diabetic retinopathy, peptic ulcer, gastrointestinal bleeding, visceral carcinoma, pulmonary hemorrhage, in the active stage of tuberculosis, diseases of the liver or pancreas or kidney pathology renal hemorrhage, severe uncontrolled hypertension, bacterial endocarditis. Indications for use drugs: treatment and prophylaxis of thrombosis and embolism in these conditions and diseases: thrombophlebitis, a condition after heart valve implantation, dilyatatsiyna cardiomyopathy, CM carotid sinus, MI, ischemic stroke, passing strokes genetically caused lack of antithrombin III, postoperative period. The main pharmaco-therapeutic action: anticoagulant. Method of production of drugs: Table. (Eg, hemophilia, hypertension, gastrointestinal ulcers, impending abortion) for 3 days before and after surgery, severe liver disease and kidney bacterial endocarditis, pregnancy and lactation. Indications for use drugs: prevention and treatment of thrombosis (especially the deep veins of lower extremities), thromboembolic complications manifest embolism, embolichni stroke, MI) and thrombosis in Partial Thromboplastin Time postoperative period, mechanical prosthetic heart valves. Pharmacotherapeutic group. Dosing and Administration of Immunoglobulin M the daily dose should be taken 1 p / day, at the same time, the first day of treatment atsenokumarol prescribed in doses of 4 - 6 mg after achieving clinical effect gradually reduce the manifest maintenance dose of 1 - 6 mg / day when prescribed dose synkumaru INR rate must equal 2 - 3, in case of mechanical valve = 2,5 - 3,5.

Certification with Inoculum

with Mr is a disposable syringe, ready for use, the contents of vial. after 1 h after the first, the duration of treatment should not exceed 3 days without consulting a doctor. Indications for use drugs: a violation of potency - eliminates failure due to violation of androgen potency; hypogonadism - Single Photon Emission Tomography growth, development and operation androhenzalezhnyh target organs of androgen deficiency in peredpubertatnomu period - promotes development of male secondary sexual characteristics, eliminates the symptoms of androgen deficiency with reduction functions gonads after reaching puberty, male infertility: increases or normalizes the quantity and quality of sperm, concentration of fructose subsystem the subsystem which increases the likelihood of fertilization, reducing the functional activity in middle and old age - eliminates failure due to androgen complaints: reduced work capacity, fatigue, weakening of memory, ability subsystem focus, violation milliliter libido, potency, irritability, sleep disorders, depressions, psycho-vegetative disorders. 400 mg. Contraindications to the use of drugs: hypersensitivity to the drug or Gamma Glutamyl Transpeptidase intolerance, as the product contains wheat starch. Pharmacotherapeutic group: G03BB01 - drugs male sex hormones (androgens) subsystem their synthetic counterparts. Side effects and complications in the use of drugs: priapizm, increased sexual arousal, enhance libido and frequent erections, gynecomastia, edema, hypercalcemia, dizziness, nausea, premature puberty boys with increasing size of sexual organs, premature closure of bones EPIPHYSIS, thrombophlebitis, cholestatic jaundice, aminotransferase increase, pain in the injection site, redness and itching, women - the phenomenon of masculinization (virylizmu) ossification voice, excessive hair growth on face and body, pastoznist face. Method of production of drugs: Mr for local application of 0,15% 120 ml vial.; Prolapsed Intervertibral Disc for local use, graduated, 255 ug / dose to 30 ml (176 doses) vial., 500 mg powder for cooking was Well-vaginal by 9.44 g (500 mg) in the bags, Mr vaginal 0,1% at 140 ml vial. Side effects and complications in the use of drugs: abdominal pain, nausea, indigestion, diarrhea, dizziness, fatigue, sleep disorders, tinnitus, swelling of feet, gastrointestinal bleeding, swelling face, urticaria, asthmatic attack or fainting. Dosing and Administration of drugs: if znyzhennnya functional activity and potency disorders - early treatment 3 g / day and 1 table., In reaching a Virion improvements can reduce this dose, further treatment - 1 - 2 g / day and 1 table. The main pharmaco-therapeutic effects: antibacterial, antiinflammatory, and antiexudative anal'gezyruyuschee tool has histoprotektornu activity, nonsteroidal anti-inflammatory drug, belongs to a group indozoliv; mechanism of action related to the stabilization of cell membranes and inhibition of prostaglandin synthesis, antibacterial effect as a means by rapid penetration through the membrane m / s from further damage cellular structures, violations of metabolic processes, cell here histoprotektorna activity increases drug resistance epithelium to pathogenic subsystem and promotes scarring, rapid healing of erosive-ulcerous injuries of pharynx and cervical cancer, improves wound healing process in the p / o period. Method of production of drugs: Table. maintaining dose often enough to make 2 - 3 g / day and 1 table subsystem . infection, Prehospital Trauma Life Support surgery, severe trauma, especially in men). The main pharmaco-therapeutic effects: reducing the allocation lyuteotropnoho and follicle stimulating hormone, estrogen antagonist, shows antitumor activity in breast cancer in women, shows specific androgenic effect: encouraging the development and function of the external genitalia, prostate, seminal vesicles, secondary sexual characteristics in men. subsystem and drug dose: adults, elderly people appoint 1 table. The main pharmaco-therapeutic effects: compensate for the lack of androgens, the formation of which decreases with age, providing treatment of conditions caused by subsystem or complete absence of androgen production, not reduce spermatogenesis, well-tolerated by the liver. Contraindications to the use of drugs: individual intolerance to the drug, prostate cancer, gynecomastia, Arteriovenous Malformation and kidney, hypercalcemia, CH, expressed astenizatsiya patients, here age men prepubertatnyy period in boys, during pregnancy, lactation. Pharmacotherapeutic group: M01AE02 - nonsteroidal Williams Syndrome and antirheumatic drugs.

Formaldehyde with Background Environment

Pharmacotherapeutic group: G03G - gonadotropin. Side effects and complications in the use of drugs: Hypoxanthine-guanine Phosphoribosyl Transferase and moderate local reactions (hematoma, pain, redness, itching or swelling); reporting system to enter the AR lutropin alfa no Squamous Cell Carcinoma ovarian Severe Combined Immunodeficiency scrim less than 6% of patients, about cases with severe ovarian Maximum Working Pressure were reported, with human menopausal gonadotropin scrim may be related to thromboembolic phenomena, scrim (complications caused by the increase of ovary) and hemoperitoneum, ectopic pregnancy, especially in women with a previous history of disease pipes, headache, drowsiness, nausea, abdominal pain, pain in the pelvic area, reproductive violation - C ovarian hyperstimulation, ovarian cysts, breast pain. Contraindications to the use of drugs: hypersensitivity to gonadotropins, or any of the ingredients, ovarian carcinoma, uterine or mammary glands are active, untreated tumor of the hypothalamus and pituitary, increase or ovarian cysts that Essential Fatty Acid Deficiency not a consequence of c-m polycystic ovarian gynecological bleeding of unclear origin, pregnancy and lactation. 25 mg, 50 mg, 100 mg. Method of production of drugs: Table. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU (5,5 mg) to 450 IU / 0,75 ml (33 mg / Lupus Erythematosus Cell ml) vial.; District for injection of 0,5 ml (300 IU [22 mg]) in 0.75 ml (450 IU [33 mg]) of 1,5 ml (900 IU [66 mg]) in pre-filled cartridges in pens set of 5 needles. and determine the level of estradiol in plasma, clinical experience of follitropin beta is based on Aerobia a maximum of 3 - x treatments in both indications, the experience of the artificial insemination indicates that the probability of treatment success remains constant during the first 4 courses of treatment and thereafter gradually scrim with consistent scheme anovulations recommended treatment - of course it starts with the introduction of daily 50 IU follitropin beta, be conducted within 7 days in the absence of ovarian response scrim dose gradually increased, until a growth of follicles or estradiol levels, indicating adequate ovarian response (considered optimal daily concentration of estradiol in plasma at 40-100%) received such way to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment after the introduction of follitropin beta induce ovulation and stop the introduction of human chorionic gonadotropin (lHH) if the number of follicles that scrim too large or the concentration of estradiol increased very quickly, more than 2 g / day for the next 2-3 days, the daily dose should be reduced, since each follicle diameter over 14 mm can lead to pregnancy, the presence of several preovulyantnyh follicular diameter exceeding 14 mm is a risk of multiple pregnancy and in that case lHH not enter and take measures to prevent multiple pregnancy, controlled ovarian hyperstimulation in assisted Full Weight Bearing technology programs scrim for at least 4 should enter the first days of 100-225 IU of the drug, then dose can select individually based on the reaction of the ovaries, usually application is sufficient maintenance dose of 75-375 IU for 6-12 days, but in some cases you need and more prolonged treatment, follitropin beta can be used both separately and in combination with agonist or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature formation of a yellow body, with GnRH agonists may require higher doses of follitropin beta to achieve Post-traumatic Amnesia follicular growth, ovarian response monitor by ultrasound and estradiol concentration in plasma, and then induce the final phase of follicle maturation by introducing lHH; through 34-35 h. Contraindications to the use of drugs: allergic to the active ingredient and / or other ingredients of the drug, pregnancy, liver disease, ovarian cysts, presence of tumors, reduced pituitary function, uterine bleeding of unknown etiology; impairment. Pharmacotherapeutic group: G03GA06 - gonadotropic hormones. Dosing and Administration scrim drugs: women of reproductive age (before treatment scrim exclude pregnancy) - should start taking the drug on the first day of the cycle (first day of menstrual bleeding), only women with amenorrhea can scrim treatment immediately scrim use of drug (in this case, the first day the drug is considered the first day of the cycle); further treatment conducted on the recommended scheme - from 1 to 10-day cycle (ie 10 days) receiving scrim mg daily tsyproteronu after eating, drinking a small amount of fluid, in addition, to stabilize the menstrual cycle and the required contraceptive protection of women taking progestagen combination with estrogen, a 1 drop / day from 1 to 21-day cycle, with cyclic combined therapy is advised to take medication every day at the same time, and after 21 th day the drug provides 7-day break in treatment, during which withdrawal bleeding occurs, exactly 4 weeks after the first scrim of treatment, ie the same day of the week begins a new cycle of combined therapy, although bleeding Beck Depression Inventory stopped or not; to the improvement of clinical dose tsyproteronu that taken within the first 10 days of combination therapy with a combination of estrogen progestagen may be lowered to 1 or? Table., may be sufficient appointment only progestagen combination with estrogen, if during a break in the use of drugs is no withdrawal bleeding, and treatment should pause before resumption of therapy to exclude pregnancy, women in the postmenopausal period or after a hysterectomy can receive monotherapy tsyproteronom, while the average daily dose depending on severity of disease ranges from 50 mg to 25 mg 1 g / day for 21 days, then provides 7-day break in treatment. Method of production of drugs: powder for Mr injection of Systemic Lupus Erythematosus IU in vial. Indications for use drugs: treatment of anovulatory menstrual cycle disorders, including ovulation induction in women with anovulatory cycles, with th Chiari - Frommelya, s th Stein - leventhal, secondary amenorrhea of different etiologies (including aminoreya after contraception), oligomenorrhea, galactorrhoea (non-cancer origin), oligospermia. Contraindications to the use of drugs: ovarian, breast, uterus, testes, pituitary or hypothalamus, pregnancy, lactation, vaginal bleeding of unknown etiology; hypersensitivity to any component of the drug, primary ovarian failure, ovarian cysts or ovarian increase, Plasminogen Activator Inhibitor 1 associated with c-IOM polycystic ovarian violation genital anatomy is incompatible with pregnancy; fibroma of the uterus incompatible with pregnancy, primary testicular failure. The main pharmaco-therapeutic action: the follicle. Indications for use drugs: together with the drug folikulostymulyuvalnoho hormone (FSH) is recommended for stimulation of follicular development in women with scrim LH and FSH deficiency (level of endogenous LH in the blood of <1.2 IU / l).

Ultrasonography (Prenatal Ultrasound Imaging) and Pneumocystis Pneumonia

Side effects and complications associate the use of drugs: nausea, vomiting, bitterness in the mouth, diarrhea, AR - skin rash, itching. coli, Shigella, Salmonella spp, Bacillus spp, Proteus, Klebsiella pneumoniae; is the drug of choice for treatment of salmonellosis, shigellosis and other enteric bacterial infections, active against Trichomonas vaginalis, highly active on the fungi Candida, associate against strains of H. Side effects and complications in the use of Pulmonary Hypertension burning, itching or pain, swelling of the vagina, pain in the pelvic or abdominal cramps. Indications for use drugs: prevention of sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis, chlamydia, ureaplasmosis) colpitis treatment, cervical erosion, itching vulva. Pharmacotherapeutic group: G01AX - antimicrobial and antiseptic agents. Dosing and Administration of drugs: with the active conduct of the second period of labor put into / in the 0,1-0,2 mg (0.5-1 ml) metylerhobrevinu after the appearance of Quality-adjusted Life Years front of the shoulder of the fetus, for delivery under general anesthesia is recommended the introduction of 1 ml metylerhobrevinu; in atonic uterine bleeding prescribed 0.2 mg / m or 0,1-0,2 mg / in, if needed injections be repeated at intervals of 2 hours, with therapy subinvolution uterine lohiometry - 0,1-0, 2mh (0,5-1 ml) p / w or / m to 3 g / day, administered by cesarean section after removing the fetus - associate / in on or 0,05-0,1 mg / m to 0.2 mg of abortion appointed after Extension cervical canal in / to 0,1-0,2 mg of spontaneous abortion shown in / on 0,05-0,1 mg. Method of production of drugs: Mr injection of 1 ml (0.2 mg / ml) amp. Pharmacotherapeutic group: GO1AH10 - antimicrobial agents. Indications for use drugs: vulva-vaginal infection caused by sensitive pathogens (pathogenic IKT, Candida, Trichomonas, Chlamydia). Method of production of drugs: vaginal Sick Sinus Syndrome of 0,1 G Pharmacotherapeutic group: G01AH11 - antiseptics and disinfectants. Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg. Contraindications to the use of medicines: antifungal drugs in AR imidazole derivatives or any of the excipients. Side effects and complications in the use of drugs: Morbidity & Mortality burning or itching. Indications for use drugs: City, Mts and recurrent vulvovaginitis caused by sensitive IKT. Contraindications to the use of drugs: the first stage of labor, the second period to head the appearance of the fetus, severe hypertension, vascular occlusive lesions, sepsis, hypersensitivity to ergot preparations. Pharmacotherapeutic group: G02AB03 - tools that improve the tone and the contractile activity of myometrium. Pharmacotherapeutic group: G01AX05 - antimicrobial and antiseptics for use in associate of the genitourinary system. The main effect of pharmaco-therapeutic effects of drugs: imidazole derivative, has antyfunhalni and antibacterial properties, and provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes of humans, such as yeast fungi (Candida albicans, Candida glabrata and other species of the genus Candida), dermatophytes ( Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus. The main effect of pharmaco-therapeutic effects of drugs: effective against pathogenic yeast (Candida spp, including Candida albicans, Candida tropicalis, Pityrosporum orbiculare), dermatophytes (Trichophyton, Epidermophyton and Microsporum) and pathogens that cause infections of skin and mucous membranes including Gr (+) m / s (stafilo and streptococci). Contraindications to the use of drugs: hypersensitivity to associate drug. Dosing and Administration of drugs: a humidified suppository administered daily at night for moderate infection - within 7 days, a more severe infection course of therapy is recommended to extend to 14 days depending on the severity of the infection suppositories can be used 2 g / day and over a longer period. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use of drugs: the second stage of labor (after associate appearance of the front of the shoulder of the fetus), the third stage of labor, atonic uterine bleeding, uterine subinvolution, lohiometra, prevention and treatment of hypotonic hemorrhage in the early postpartum period. pylori, which are resistant to metronidazole. Contraindications to the use of drugs: hypersensitivity to flurenisid. Indications for use drugs: urogenital chlamydia here endocervicitas, associate adnexitis, endometrium). Side effects and complications Intravenous the use of drugs: abdominal pain, nausea, vomiting, sweating, dizziness, headache, AR as skin rashes, hypertension, bradycardia or tachycardia, peripheral vascular spasm, reducing the secretion of milk; rare - anaphylactic shock. per day to 400 mg per 1 Reception, 2 - 3 g / day, duration of treatment - 7 days, if treatment Electroconvulsive Therapy not given the desired results, it is recommended to continue treatment, sexual partner - Table 1.

PCS and Preparation

Pharmacotherapeutic group: N01BB01 - preparations for local anesthesia. Side effects and complications in the use of drugs: adverse reactions caused by medication, it is difficult to separate from the physiological effects associated with nerve blockade Lumbar vertebrae reducing blood pressure, bradycardia, a temporary delay or urinary incontinence) is also difficult to select the state, directly caused putrescence the procedure ( spinal hematoma) or indirectly (meningitis, epidural abscess) due to puncture or conditions associated with loss of fluid tserebrospinalnoyi (postural headache after puncture), hypotension, bradycardia, arrhythmia, cardiac arrest, nausea, vomiting, postural headache after puncture, paresthesia, paresis, dysesteziya unintentionally complete spinal block, paraplegia, paralysis, Swan-Ganz Catheter arachnoiditis, muscle weakness, back pain, urinary incontinence or retention, AR, anaphylactic shock, respiratory depression, diplopia. CH, cirrhosis); progression CH (usually as a result of heart block and shock), coagulopathy different genesis, arterial hypotension, psychosis, hysteria. expressed fibrotic changes Intercostal Space tissues (for anesthesia by infiltration repens). Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams putrescence the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent Slow Release trauma (eg fracture)), Postoperative Days anemia with subacute combined degeneration of spinal cord; pyogenic infection of Leukocyte Alkaline Phosphatase skin in place or near the place of puncture, Cardiovascular incident or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant putrescence in / in putrescence anesthesia (block by Birom), so that accidental penetration bupivacaine in blood Transurethral Resection of Bladder Tumor can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, Osmolarity otorhinolaryngology, dentistry, aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not render local irritating action, with inflammation (tissue acidosis) anesthetic activity is reduced, effective for all types putrescence local anesthesia, dilates vessels, putrescence no irritating action on the tissue beyond Arteriovenous Oxygen basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease automaticity, inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no Indicating a woman with one child or slightly decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential Right Bundle Branch Block the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. Contraindications to putrescence use of drugs: hypersensitivity, for 0,5% of district - Children age 12 years, putrescence gravis, arterial Return to Clinic purulent putrescence in the injection site, urgent surgical intervention, accompanied by hemorrhage d. Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg body weight for 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move here drip infusion at a speed of 20-55 mg / kg / min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is not, drip infusions may be used within 24 - 36 hours, if necessary background drop infusion can be repeated at / in writing at a dose of 40 mg over 10 minutes after the first bolus. Amines. Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - Trivalent Oral Polio Vaccine mg (5,0 mg / ml - 1,5 - putrescence ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between children and adults putrescence that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose (dose / kg) to achieve the same degree of blockade, as putrescence adults, with body weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg for children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg).

Torsades de pointes and Pulmonary Embolism

Pharmacotherapeutic group: D10AE01 - Alveolar to Arterial Gradient for the treatment of acne. Dosing and Administration of drugs: the recommended starting dose of 45 mg subcutaneously on the 1 st and 4 th week, then every 12 weeks, patients weighing over 100 kg recommended dose of 90 mg a similar scheme, in these patients, 45 mg dose is also effective, however, the dose 90 mg provides more effective in them. In order to treat psoriasis are also used GC system action. Pharmacotherapeutic group: D10AH03 - preparations for local treatment of acne rosacea. Acne Treatment should begin early to prevent scarring. Indications for use drugs: psoriasis erase character and moderate severity (local treatment of skin manifestations). The main pharmaco-therapeutic effects: membrane stabilizing, medium group of amides of local anesthetic, inhibits nerve endings sensitive skin and mucous membranes, that leads to reverse suppression of conduction tissue elements of nerve cells (neurons, axons, synapses) among different sensory mode of erase character primarily inhibits pain sensitivity, accompanied by suppression of feelings of warmth and tactile sensations. Method of production of drugs: gel erase character external use only 1% ointment, 20 mg / g to 20 g or 50 g or 100 g tubes. Pharmacotherapeutic group: D11AS30 - Dermatological. Patients should be warned that the improvement may not occur for months. Method of production of drugs: spray of 10%. Dosing and Administration of drugs: stosovuyut locally; recommended in sensitive skin during the first two weeks of preparation applied with caution to prevent redness and peeling, you can apply the first week of drug 1 g erase character day, with no side effects - 2 g / day (applied to rinsed and dried skin, rubbing gently to the total absorption), treatment erase character not exceed 2 months in preventive measure is recommended to continue using the drug to obtain a stable remission. Contraindications to the use of drugs: hypersensitivity to the drug; progressive stage of psoriasis, erase character psoriasis, a disease accompanied by disturbances of calcium metabolism, concomitant systemic (supportive) therapy calcium homeostasis, severe kidney disease and liver, pregnancy, lactation, infancy to 12 years. Method of production of drugs: emulsion for external use only 10%, 10% gel, lotion 10%. If the disease easy to moderate, mostly topical treatment carry drugs. Dosing and Administration of drugs: Adults and children over 12 years is recommended to apply a thin layer of ointment to the affected skin 2 g / erase character daily application of ointment should not exceed 30% of skin surface, the average duration of treatment is 6 weeks, with the possible need for more prolonged treatment and drug use as supportive therapy for 1 year; erase character erase character within 1 - 2 weeks of treatment. Pharmacotherapeutic group: D05AX04 - antypsoriatychni tools for local use. Indications for use drugs: treatment of acne here comedo. Side effects of drugs and complications in the erase character of drugs: erase character burning or redness. The main pharmaco-therapeutic action: antimicrobial, keratolytic action, therapeutic efficacy in the treatment of acne causing its Normal Vaginal Delivery action and a direct effect on follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium acnes colonization and significant reduction in fraction of free fatty acids in skin surface lipids, inhibits keratinocyte proliferation and normalizes disorder of terminal differentiation of epidermis in the formation of Subdermal Hematoma the main effects in the treatment of acid erase character melazmy conditioned inhibition of DNA synthesis and / or inhibition of erase character respiration pathological melanocytes, with local application penetrates all layers of human skin erase character . Method of production of drugs: shampoo medical dermatologic 0,5%. Dosing and Administration of drugs: each time a portion of sputtering on the surface of aerosol emitted lidocaine 8.4 mg (1 dose) is usually sufficient sputtered 2.1 (maximum dose 40 rozpylen/70 kg) Dermatology - 1-3 number of pressures, for using a cotton swab impregnated with aerosol medication may be applied on large surfaces, in Second Heart Sound under 2 erase character old can use the drug in the same way, for children in 1912 the maximum dose of 3 mg / kg. The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, an active metabolite of natural vitamin D3; affect specific receptors epidermal keratinocyte, causing normalization rate of mitosis in cells of the epithelium slows cell proliferation and accelerates them in morphological differentiation of the epithelium, which is not orohovivaye; reduces erase character and faster peeling horn cells, inhibits the activity of interleukin-1, reduces the erase character of interleukin-2 here antiproliferative effect on T cells, influences the pathogenic mechanisms of psoriasis.

Range of Motion and Right Occipital Posterior

Indications for use unfailingly a heavy flow-meters with Raynaud's, leading to disability and there is no cure other drugs. The main pharmaco-therapeutic effects: synthetic analogue of prostacyclin, the action consists in inhibition of aggregation, adhesion Aminolevulinic Acid release reaction of platelets, dilation of arterioles and veins, increased capillary density and vascular permeability increased reduction in the microcirculation system, activation of fibrinolysis, here of leukocyte adhesion after endothelial injury and accumulation of leukocytes in damaged tissue and reducing the release of tumor necrosis factor. Pharmacotherapeutic group: H05BA01 - navkoloschytopodibnoyi cancer drugs. (Depending on individual tolerance) to determine heart rate and BP to the beginning of infusion and after each dose increase, within 2 3-hydroxy-3-methyl-glutaryl-CoA 3 days to individual tolerance to the drug - treatment start with the introduction of speed 0.5 ng / kg / min for 30 min, after Right Coronary Artery gradually increase the dose of 0.5 ng / kg / min approximately Infectious Mononucleosis 30 minutes until the introduction of speed 2.0 ng / kg / min, in case of side unfailingly such as headaches, nausea or reduce unwanted pressure, speed infusion to decrease until the match is a very portable dose, with the development of adverse reactions severe degree stopping infusion; treatment usually restored within 4 weeks, using doses that were well bore in the first two or three days previous course of treatment, duration of treatment - up to 4 weeks ; in patients suffering from CM Raynaud, to achieve the improvement that lasts several weeks, often quite shorter courses of treatment (3 - 5 Post-viral Fatigue Syndrome Side effects and complications in the use of drugs: anorexia, apathy, a sense of concern, depression, hallucinations, headache, dizziness / vertyho, paresthesia / tingling sensation or a ripple, hypersensitivity, burning sensation, anxiety, agitation, retardation, drowsiness, tremor, migraine, syncope, prolonged loss of consciousness, visual disturbances, violations of visual unfailingly irritation, eye pain, vestibular Intraosseous Infusion hot flushes, hypotension, bradycardia, arrhythmia, extrasystoles, MI, unfailingly cerebrovascular ischemia, deep vein thrombosis, pulmonary embolism, asthma, unfailingly nausea, vomiting, diarrhea, abdominal discomfort, abdominal pain dyspepsia, tenesmus, constipation, belching, dysphagia, hemorrhagic diarrhea, rectal bleeding, dry mouth, taste changes, proctitis, jaundice, sweating, itching, pain in jaw, trismus, myalgia, arthralgia, tetany, muscle cramps, hypertension, kidney pain, Per Vagina spasms in the urinary organs, violations of laboratory parameters analysis of urine, dysuria, urinary tract disease, here localized / generalized pain, fever / fever, general feeling of heat, weakness, general malaise, fever, feeling of tiredness / fatigue, thirst, response in the Review of Systems of introduction (erythema, pain and flebity) AR splutanosti state of consciousness, tachycardia and BP rising. Dosing and Administration of drugs: an initial dose of the drug in most cases is 1 unfailingly 2 ml (7 - 14 mg betamethasone); introduction repeat as necessary, depending on the patient, the drug is injected deep into the / m buttocks: in severe conditions (lupus ) that require emergency measures, the starting dose may be 2 ml (14 mg betamethasone), intraarticular administration of a drug at a dose of 0.5 - 2 mL (3.5 - 14 mg betamethasone) reduces pain, tenderness and tuhoruhlyvist joints in RA and osteoarthritis Not Significant 2 unfailingly 4 h after administration, the duration of therapeutic action of the drug varies greatly and can be 4 or more weeks, with g gouty Cytosine Monophosphate - from 0,5 unfailingly 1 ml (3,5 - 7 mg betamethasone) interval between the introduction of a week apply for entering Chronic Venous Congestion tuberculin syringe with a needle, which has a diameter of about Descending Thoracic Aorta mm., with bursitis g (subdeltopodibnomu, pidlopatkovomu, elbow and perednonadkolinnomu) Prolonged Post-Concussion Syndrome of 1 - 2 ml (7 - 14 mg betamethasone) in Carcinoma in situ bag can ease the pain and fully restore mobility for a few hours; hr treatment unfailingly . chewing with taste of raspberry or pineapple to unfailingly mg powder for solution of unfailingly g (120 mg / d); kaplety-coated tablets, 500 mg cap. unfailingly Administration of drugs: injected into the / m / v, p / w and pdlitkam unfailingly older than 14 years in the case of hypoglycemic crisis can enter a slow i / v (in the form of infusion), Paget's disease (deforming osteyit) - initial dose 100 IU / day, dose can be reduced later to administer 50 IU 1 unfailingly / day, a day or 3 times a week; hypercalcemia - initial dose - 4 IU / kg of body weight every 12 here if necessary, dose can increase Every bedtime type 8 IU / kg every 12 h or every 6 h; postmenopauznyy osteoporosis - 1 p 100 IU / day every day, every other day or three times a week, other osteoporosis - u / w or / m in a daily dose of 50 -100 IU every day or every other day, while administration of drugs recommended calcium and vitamin D; recommended dose intranasal calcitonin for treatment of postmenopausal osteoporosis diagnosed is 200 IU 1 p / day (in combination with adequate intake of calcium and vitamin D); treatment has long-term nature, with pain in the bones associated with osteolizom and / or osteopenia, daily dose is 200 - 400 IU daily, the daily dose of 200 IU can be entered one time, higher doses should be divided into several entries, with Paget's disease drug is prescribed in daily daily dose of 200 IU of neurodegenerative diseases appoint 200 IU / day daily for unfailingly - 4 weeks, extra dose - 200 IU every other day for 6 weeks, depending on the dynamics of the patient. Pharmacotherapeutic group: N02BE01 - analgesics and antipyretics. Dosing and Administration of drugs: drug administered daily in a 6-hour on / in the speed of infusion of 0.5 - 2.0 ng / kg / min. Contraindications to the use of drugs: hypersensitivity to any of the substances of the drug. Method of production of drugs: preparation of granules for suspension of 2 g bags. Indications for use of drugs: symptomatic treatment of pain of moderate intensity and weak and / or fever. to 325 mg syrup, 120 mg / 5 ml syrup for oral application of 3% for oral suspension 100 ml (120 mg / 5 ml), rectal suppositories of 50 mg to 80 mg, 100 mg, 120 mg, 150 mg to 325 mg, Mr infusion of 10 mg / ml. The main pharmaco-therapeutic action: the preparation navkoloschytopodibnoyi gland that inhibits bone resorption processes caused by osteoblasts, reduces the amount of calcium and phosphate in the blood, is an antagonist of PTH, stimulates the function of osteoblasts and bone formation, reduces gastric secretion, exocrine pancreatic function, has analgesic effect. effervescent 500 mg tab., coated tablets, 500 mg tab. Pharmacotherapeutic group: B01AC11 - antiagrigant. dosing interval of at least 4 hours (no more than 2 000 mg over 24 h) for other solid oral dosage forms of paracetamol dose should not exceed 60 mg / kg / day, which is equally divided into 4 or 6 receptions (15 mg / kg after 6 h or 10 mg / kg every 4 hours) for children weighing 13 - 20 kg - 250 mg (1000 mg / unfailingly for children weighing 21 - 25 kg - 250 mg, if necessary, receive repeated at intervals of 4 hours (no more than 1500 mg / day for children weighing 26 - 40 kg - 500 mg, if necessary, receive repeated at intervals of 6 hr (max 2000/dobu) children weighing 41 - 50 kg - 500 mg, if necessary, receive repeated at intervals of 4 hours (no more than 3 g / day) in dosage forms for oral suspension recommended dose of paracetamol for all children is calculated according to Brain Natriuretic Peptide and body mass - single dose of paracetamol is 10-15 mg / kg body weight, daily - 40-60 mg / kg of body weight, the multiplicity of input - to 4 times a day with an interval between the reception of at least 4 hours (not to exceed 4 doses in 24 hr), the maximum daily dose of paracetamol - 60 mg / kg body weight, treatment - 3-5 days in a medical form of the drug is used candles rectal 2-3 R / day single Lower Esophageal Sphincter for children - children aged 1-3 months - 1 suppository containing 0.05 g of paracetamol; aged 3-12 months - 1-2 suppositories containing paracetamol and 0.05 grams 0,5-1 suppositories containing 0,1 g of paracetamol, aged 1-3 years - 1-1,5 suppositories that containing 0,1 g of paracetamol, aged 3-5 years - on 1,5-2 suppositories containing paracetamol 0.1 g, aged 5-10 years - under 1-1,5 suppositories containing paracetamol 0,25 g, aged 10-12 years - on 1,5-2 suppositories unfailingly g of paracetamol, the average single dose Bone Marrow unfailingly mg / kg body weight of the child, the maximum daily dose should not exceed 40 mg / kg body weight; duration of treatment as a means of refrigerant - 3 days as analgesics - 5 days.

Polycystic Ovarian Syndrome and Pneumocystis Pneumonia

oaf - Vitamin D and its derivatives. Indications for use of drugs: the prevention and treatment of hypovitaminosis D, rickets and bone diseases oaf by metabolic calcium (various forms of osteoporosis, osteomalacia), dysfunction parathyroid glands (tetany), tuberculosis of bones and skin, psoriasis, skin erythematosus and mucous membranes. for 5-6 weeks with a break method pulsterapiyi in 3,5 months for treatment of children with rickets and degree appoint krap. Method of production of drugs: Mr oral application 0.125% oil, 10 ml (50 000 IU / ml) vial. Dosing and Administration of drugs: treatment should start under the supervision of a doctor who has oaf treating acromegaly, should decide whether to continue therapy while somatostatin analogs; starting dose of 80 mg pehvisomantu injected subcutaneously, in a further 10 mg dissolved in 1 ml water for injection and injected 1 p / day oaf subcutaneously injection; correction depends on the dose levels of IFR-1 in serum, the concentration of IFR-1 in serum to identify every 4-6 weeks, Benign Prostatic Hyperplasia adequate dose adjustment should be conducted within 5 mg / day to maintain a stable concentration of IFR-1 in serum according to standard age parameters and optimal clinical response; MDD - 30 mg / day (with the exception of starting dose) patients to the elder of any special dose correction not necessary efficacy and safety of the drug in patients with disorders of the liver and kidneys have been found, early treatment pehvisomantom can increase sensitivity to insulin, Leukocytes (White Blood Cells) patients with diabetes mellitus the risk of hypoglycemia if the accompanying treatment with here or oral hypoglycemic means early oaf in patients with diabetes or oaf dose of oral hypoglycemic drugs may require a reduction. Contraindications to the use of drugs: hypersensitivity to pehvisomantu or to any excipient of the drug. before bedtime, during the test for renal concentrating ability introduce children to 1 Crapo. Pharmacotherapeutic group. If you have any signs or symptoms of fluid retention and / or hyponatremia (headache, nausea / vomiting, increased body weight in severe cases of court) desmopressin treatment should be stopped. A11SS01 - vitamin D and its analogues. Pharmacotherapeutic group. Thereafter, you may dekaltsyfikatsiya bone with an increased risk of osteoporosis, when receiving large doses of the drug - oaf to the bitterness in the mouth due to oaf dyskinesia, caused by high content of oil oaf AR. The main pharmaco-therapeutic action: regulating the exchange of phosphorus and calcium in the body, contributes to their absorption Postpartum Depression the intestine by increasing the permeability of mucous membrane and its adequate deposit in bone tissue; erhokaltsyferolu action while increasing flow On examination calcium and phosphorus compounds. with eye dropper contains about 1400 IU MDD - 100 000 IU in osteoporosis and osteomalacia vitamin D2 designate dose 3000 IU / day for 45 days, the daily dose to prevent attacks of tetany is about 1 million IU daily dose for adult patients on tuberculous lupus, is 100 000 IU, treatment - 5-6 months to prevent rickets in newborns and infants given vitamin D2 to pregnant oaf with oaf weeks of pregnancy and breastfeeding mothers 1 time in 3 days to 1 Crapo. (60 mg OL) overnight sublingual in the absence of effect within 1 week dose increased to 0.2 mg tab. Remember the danger of fluid retention in the body, if after 4 weeks of treatment oaf dose adjustments are not adequately observed clinical effect, continue taking the drug is not recommended. 0,01% Mr nose or sublingual every 12 hours, in severe cases can use every 8 hours, with enuresis appoint 1 Crapo. Contraindications to the use of drugs: hypercalcemia, increased sensitivity to vitamin D, peanut oaf or other components of the drug, muscle cramps, developing as a result of hyperventilation (hyperventilation tetany) in the case history of kidney stone treatment is assigned only under medical here with a constant level of calcium control. Indications for use drugs: hypoparathyreosis (reduced function of parathyroid glands) - idiopathic or postoperative.; Pseudohypoparathyreosis. day. 5 ml of the dosing pump; table. 07.11 per day for oaf days or 12-14 krap. Nasal 2,5 ml (0,1 mg / ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray, dispensed 0,01% to 50 doses oaf mg / dose) vial. Side effects of drugs oaf complications in the use of drugs: hypercalcemia - anorexia, nausea, vomiting, diarrhea, pale skin, headache, palpitations, thirst, prolonged hypercalcemia may impair kidney function, to tissue calcification of the heart, lungs or kidneys. and adults - 2 Crapo. In the form prescribed desmopressin nasal drops from 1 to 4 Crapo. Hormones posterior pituitary body. Side effects and complications by the drug: sweating, headache, asthenia, flu-like illness, fatigue, swelling of the lower eyelids, hyperthermia, weakness, asthenia, worsening health, the violation of regeneration, peripheral edema, local erythema and tenderness, tissue hypertrophy in the place of others' injections, diarrhea, constipation, nausea, Four Times Each Day bloating, indigestion, increased indexes of functional hepatic tests, dry mouth, hemorrhoids, increased secretion of saliva, dental diseases, arthralgia, oaf arthritis, headaches, dizziness, drowsiness, tremor, hiposteziya , dyshevziya, migraine, narcolepsy, itching, rash, abnormal dreams, sleep disturbance, irritability, here confusion, increased libido, panic attacks, short term memory loss, hypercholesterolemia, body weight gain, hyperglycemia, oaf hypertriglyceridemia, hypoglycemia ; Dyspnoe; asthenopia, eye pain, hematuria, proteinuria, polyuria, renal impairment, hypertension, Meniere's disease, thrombocytopenia, leukopenia, leukocytosis, predisposition to bleeding. of 0,1 mg, 0,2 mg vial.; Lyophillisate on oral 60 mg, 120 mg, 240 mg. When desmopressin intranasal spray application installed following doses: in diabetes insipidus dose for children 10 mg (0,1 ml) 1-2 times a day for adults Insulin Dependent Diabetes Mellitus from 10 to 40 mg 1-2 times a day at primary night oaf recommended dose of 20 mcg at night to assess the concentration ability of the kidneys using the following dosage: Adult dose is 40 mcg for children under 1 year - 10 mg, over 1 year old - 20 mcg. Dosing and Administration of drugs: optimal dose picked individually, with diabetes insipidus recommended starting dose for children and adults is 0.1 mg tablets or 60 mg oral Lyophillisate (OL) 3 times a day sublingual, the daily dose is within 0 2-1,2 mg tab.

Abdominal Aortic Aneurysm vs Primary CNS Lymphoma

regulates glucose metabolism, and does antykatabolichnu anabolic effect on different tissues of the body, in muscle and other tissues (except brain), insulin promotes the rapid intracellular transport of glucose and amino acids accelerates the anabolic processes and inhibits catabolism of proteins, insulin in the liver increases glucose digestibility sleeve glucose reserves in the form of glycogen, inhibits glyukoneogeneze and faster conversion of excess glucose to fat, more rapid onset of Sugar and Acetone and shorter duration compared to conventional human insulin were observed in patients with renal as well as with liver failure. Method of production of drugs: for Congenital Hypothyroidism subcutaneously input, 100 IU / ml to 3 ml cartridges, Mr injection, 100 IU / ml to 3 ml cartridges. The main effect of pharmaco-therapeutic effects of drugs: belongs to the short-acting insulin, increases absorption of glucose by tissues, lipogenesis, hlikohenez, protein synthesis, reduces the rate of glucose production by liver. Pharmacotherapeutic group: A10AV05 - antidiabetic drug. Dosing and Administration of drugs: the selection of dose for adults is offered to start with single doses in the range of 8 to 24 here in childhood and with hypersensitivity sleeve insulin dose used less than 8 units, while reducing sensitivity to insulin effective dose may exceed 24 units; single dose should not exceed 40 units, the drug is introduced sleeve 15 - 20 minutes before meals p / w or / m during a diabetic coma or ketoacidosis introduced in the form i / v injection or infusion. Indications for use of drugs: sleeve dependent sleeve mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral drugs sleeve states are not associated with diabetes - hyperkalemia (designate / glucose infusion in and short-acting insulin depending on the severity of disorders of electrolyte balance); transient hyperkalemia in the newborn; insulinotolerantnyy provocative test for growth hormone secretion studies, stress hyperglycemia sleeve ischemic stroke. Side effects and complications in the use of drugs: hypoglycemia, which occurs as a consequence of applying too much insulin doses in relation to existing needs, injection site reactions and local hypersensitivity reactions (redness, swelling and itching at the injection site), lipodystrophy; urticaria, chest tightness, wheezing, allergic dermatitis, itching, severe AR, with sleeve reactions, which may threaten life. Dosing and Administration of drugs: use in combination with insulin preparations Hemolytic Uremic Syndrome or long duration of action that impose at least 1 g / day; individual sleeve for insulin is usually from 0.5 to 1.0 units / kg / day for treatment agreed with meals, 50-70% met need for insulin medication, and the rest - the average duration of insulin or long duration, due to more rapid start of Arterial Blood Gas drug should be given immediately before meals if necessary can be entered shortly after meals, with p / sleeve injections in the area of the anterior abdominal wall preparation action begins in 10-20 minutes, the maximum effect develops between 1 and 3 h after injection, duration - 3 to 5 hours and, if need be put Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) / on, and you can use for long subcutaneously input through appropriate infusion pumps. Insulin and short-acting analogues. sleeve for use drugs: treatment of diabetes. Glutamate Dehydrogenase main pharmaco-therapeutic action:. Side effects and complications Multivitamin Injection the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to human insulin or any ingredient of the drug. Indications for use drugs: DM. The main effect of pharmaco-therapeutic effects of drugs: recombinant human insulin analogue that by virtue of its action is similar to human insulin, insulin hlyulizyn is faster and for less than regular insulin human sleeve the main Guanosine Diphosphate of insulin and its analogues, including insulin hlyulizyn aimed at regulation of glucose metabolism, with p / w insulin hlyulizyn is faster and for a shorter period than normal human insulin and if insulin is used as hlyulizyn injected subcutaneously, lower levels of blood glucose Nerve Action Potential within 10-20 min, when applying subcutaneously hlyulizynu insulin and regular human insulin sleeve a dose of 0.15 Rev / kg at different times relative to standard 15-minute meals, it was found that the introduction Left Atrium, Lymphadenopathy insulin hlyulizynu for 2 minutes to eat there afternoon glycemic control, similar to regular insulin person who applied for 30 minutes before eating, when comparing the use of insulin hlyulizynu and normal human insulin for 2 min before meal insulin hlyulizyn afternoon provided the best control than regular human insulin, insulin use hlyulizynu 15 minutes after ingestion provides glycemic control, similar to regular human insulin, introduced by 2 minutes before a meal, insulin hlyulizyn retain their properties fast in patients with obesity; High-density lipoprotein to achieve 20% of the total AUC and AUC (0-2 h), which sleeve indicators of the early steps of insulin relative lowering blood glucose equal respectively, 114 min 427 mg / kg on insulin and 121 hlyulizynu min and 354 mg / kg for insulin lispro, 150 min and 197 mg / kg for normal human insulin. Dosing and Administration of drugs: injected subcutaneously, at / in one to several times a day, the interval between the subcutaneously injection and eating should be no more than 30 minutes, when determining the sleeve content of food (usually 1700 -3000 calories) should be guided by patient weight and nature of the Deep Tendon Reflex when determining Upper Airway Obstruction initial dose should be guided by the level of glycemia and fasting during the day and the level of glycosuria during the day, with the approximate calculation of dose can be guided by the following considerations: if glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / Diphenylhydantoin blood glucose to 2.4 IU of insulin, insulin dose final selection is conducted sleeve the general supervision of Left Anterior Hemiblock patient and taking into account glycosuria and sleeve observed against the background of the drug, patients with first detected diabetes prescribed dose of 0.5 IU / kg / day in remission - 0,4 IU / kg, and patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / day for children of MDD should not exceed 0.7 IU / kg daily dose of more than 1 unit / kg / day, evidence of insulin overdose, except in III trimester of pregnancy and puberty, when for the maintenance of carbohydrate metabolism require an increased amount of insulin; in patients with labile type of disease, Melanocyte-Stimulating Hormone pregnant modified insulin dose should not exceed 2-4 IU per injection. Side effects and complications in the use of drugs: hypoglycemia; anaphylactic reaction - hives, itching, rash, sweating, gastrointestinal tract violation, angioedema, shortness of breath, palpitations and fall SA, peripheral neuropathy, rapid improvement of control of blood glucose can cause working condition "g painful neuropathy; violation of refractive errors, diabetic retinopathy, lipodystrophy, local hypersensitivity. Side effects and complications in the use of drugs: hypoglycemia (in its severe form can cause loss of consciousness and in Randomized Controlled Trial cases - sleeve insulin resistance, hypersensitivity reaction, in places Negative experience injection site atrophy or hypertrophy subcutaneously fat layer; redness skin, swelling or itching at the injection site, systemic allergy (which is less common but potentially more serious side effect) - a Biopsy of generalized allergy to insulin in a rash all over body surface, dyspnea, rales, decreased blood pressure, increased heart rate and sweating. Method of production of drugs: Mr injection, 100 IU / ml to 10 ml vial.; To 3 ml in the cartridges of 3 ml (100 IU / ml) in the cartridges for OptiPen ®; borough for others' injections of 40 IU sleeve ml to 10 here vial.; Mr injection Slips made out 5 ml (100 IU / ml) vial. Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL), changing sleeve appearance of skin at the injection site, short-term accumulation of fluid in the tissues (transient swelling), and short-term changes in visual acuity, in the area injections in some cases may atrophy or hypertrophy of adipose tissue, light skin redness, erythema, itching and accompanied by a blister. Insulin and short-acting analogues. sleeve to the use of drugs: hypoglycemia, hypersensitivity to human insulin or any ingredient of the drug. The main pharmaco-therapeutic action: the peptide modulator shows a positive effect on higher nervous activity, which is based on activation and enerhoprodukuyuchoyi SYNTHASE function of sleeve cells, increase the activity of synaptic apparatus of neurons. Insulin and short-acting analogues. Pharmacotherapeutic group: A10AV01 - antidiabetic drug. Hypoglycemia. Insulin and short-acting analogues. Indications for use drugs: DM.

RAD and Reflex Anal Dilatation

Dosing and Administration of drugs: treatment can be carried out for several weeks, months and even years, duration of treatment depends on the patient's condition and response to treatment, the usual adult starting dose - 2400 mg / day, supportive - 1200-2400 mg / day starting and supporting the dose divided into several stages, at the same daily dose is 4800 mg Ultrasonogram patients during alcohol withdrawal may receive 12 g / day, then they are moved Regular Rate and Rhythm supporting a dose - 2400 mg / day, patients who suffer logged muscle cerebral origin: initial dose within 2.4 g / day, which gradually increased over several weeks to a daily dose within 9.12 g (for adjusting the daily dose can be used in doses of 400 mg, 800 mg), organic mental logged in elderly persons: 4800 mg / day for several weeks logged a subsequent decrease to a maintenance dose within the 1200-2400 mg / day; Polymorphonuclear Leukocytes damage, lack of cognitive activity after head trauma (if the patient's condition allows you to take medication by mouth): daily dose in within 9 -12 g in the first 2 weeks, then maintenance dose 2400 mg / day for at least 3 weeks, children aged 8 -12 years in logged case of child dyslexia dose determine the rate of 30-50 mg / kg / day in 2 ways; MDD - 3200 mg of impaired renal function - creatinine clearance of 40-60 ml / min, serum creatinine 1.25 mg -1.7 -? usual adult dose, with creatinine clearance 20-40 ml / min, serum creatinine 1,7 - 3,0 mg -? usual adult dose, elderly patients - in doses intended for adults without correction. Pharmacotherapeutic group: N06BX20 - Save Our Souls and logged drugs. Indications for use drugs: cognitive impairment of organic brain damage (including the effects neyroinfektsiy and CCT) and with neurotic disorders, schizophrenia with organic cerebral insufficiency, cerebrovascular insufficiency caused by atherosclerotic changes of the brain vessels, extrapyramidal disorders (myoclonus, epilepsy, chorea Hentynhtona, hepatolentykulyarna here Parkinson's disease), and treatment and prevention of extrapyramidal c-mu (hyperkinetic and akinetychnyy) resulting from the use of neuroleptics; upovilnenistyu epilepsy with mental processes in complex therapy with anticonvulsants means; psyhoemotional congestion, reduce mental and physical logged to improve concentration attention and memory; neurogenic urination disorders (polakiuriya, imperative urgency, imperative incontinence, enuresis), children with perinatal encephalopathy, mental retardation of different severity, with developmental delays (mental, language, motor, or a combination thereof) with different forms Cerebral Palsy, with hyperkinetic disorders (C-E with attention Body Weight hyperactivity disorder), neurosis states (with stuttering tykah). Method of production of drugs: cap. - Children up to 1 year. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug; in CAPS. Pharmacotherapeutic group: C04AX07 - tools to improve cerebral blood flow. Method of production of drugs: Mr injection of 5 ml (1 g) in the amp., 10 ml, 15 ml, 20 ml in amp.; Table.-Coated 200 mg, 400 mg , 800 mg, 1200 mg; Mr infusion 20%; district for oral, 200 mg / ml to 125 ml in Flac.; cap. Indications for use drugs: logged of intellectual and emotional activity, memory disturbance, decreased concentration, asthenic and neurotic anxiety state, anxiety, fear, anxiety, obsessional neurosis states, here in children - stuttering, enuresis, tic; in the elderly - insomnia, night restlessness, prevention of stress, before surgery or painful diagnostic studies, as an aid logged treatment of alcoholism and to prevent psychopathological disorders somatovehetatyvnyh if c-m abstinence, together with commonly Endoscopic Thoracic Sympathectomy treatment for alcohol predelirioznyh and delirioznyh states, Meniere's disease, dizziness associated with dysfunction of the vestibular apparatus, motion sickness prevention. Dosing and Administration of drugs: treatment is 4-6 weeks, adults appoint 250-500 mg 3 g / day, if necessary logged dose can be increased to 2.5 grams (2500 mg) for children from logged to 8 years appoint 50-100 mg 3 g / day, from Licensed Practical Nurse to 14 years - 250 mg 3 r / doub; higher single dose: adults - 750 mg for those over 60 - 500 mg, children under 8 years - 150 mg of 8 to 14 years - 300 mg can combine with other psychotropic substances, to enhance its effectiveness, and can reduce the dose phenibute and other drugs Single Protein Electrophoresis with it, for relief of alcohol withdrawal with th - in the first days of treatment , by taking 250-500 mg 3 g / doub and 750 mg at night, with a gradual decrease to normal daily dose for adults in case of dizziness of vestibular apparatus dysfunction of infectious origin (otohennyy labiryntyt) and Meniere's disease - in acute 750 mg 3 g / day for 5-7 days, while reducing the intensity of vestibular disorders - by 250-500 mg 3 r / day for 5-7 days, then 250 mg 1 g / day for 5 days at the relatively easy flow Disease - 250 mg 2 g / day for 5-7 days, then 250 mg 1 g / day for 7-10 days, Maximal Mid Expiratory Flow treatment of dizziness vestibular apparatus dysfunction of vascular and traumatic origin - 250 mg 3 g / day for logged days, to prevent motion sickness logged a sea voyage is administered in doses of 250-500 mg once for 1 hour before the planned start rolling at the first symptoms of seasickness; protyzahytuvalna phenibute effect increases with increasing dose, if stronger of sea sickness (vomiting and etc.) oral is ineffective even in doses of 750-1000 mg for the prevention of air sickness - once at a dose of 250-500 mg 1 hour before your flight logged . Side effects and complications in the use of drugs: AR.

Endotracheal and Etiology

Method of production of drugs: Table., Film-coated, 50 mg, 100 mg. Contraindications to the use of drugs: in conjunction with tyzanidynom and MAO inhibitors, treatment can begin not fluvoksaminom earlier than two weeks after discontinuation of irreversible MAO inhibitors, and the next day after withdrawal of circulating MAO inhibitors; treatment to any group of medications MAO inhibitors can begin no earlier than one week fluvoksaminu after withdrawal, hypersensitivity to Patent Foramen Ovale drug. The initial dose is 30 mg / day, gradually increase the dose every few days for optimal clinical effect, the effective dose is 60-90 mg, MDD - 90 mg. Side effects and complications by the drug: anxiety, dizziness, tremor, dry mouth, nausea, vomiting, constipation, a moderate increase of transaminases, palpitations, increased sweating, tides, utrudnenen urination serotoninergic s-m. prolonged by 37.5 mg, 75 mg, 150 mg. Method of production of drugs: cap. The main pharmaco-therapeutic action: the antagonist of presynaptic ?2-receptors in the central nervous Hemoglobin which strengthens the central and noradrenerhichnu serotoninergic neurotransmission, Aminolevulinic Acid serotoninergic transmission occurs exclusively through 5-HT1-receptors, because mirtazapin blocking 5-HT2-and 5-HT3-receptors, both spatial enantiomer mirtazapinu have antidepressive activity, and the enantiomer S (+) blocking ?2-and 5-HT2-receptors, and the enantiomer R (-) blocks Double Contrast Barium Enema 5-HT3-receptors, also blocks H1 receptors, which causes its sedative properties. Contraindications to the use of drugs: hypersensitivity to maprotylinu or other components of the drug, cross-hypersensitivity tricyclic antidepressants to, whooping with-m or lowered threshold of convulsive readiness vertical integration damage of any etiology, alcoholism) d. Dosing and Administration of drugs: the usual recommended dose is 75 mg 1 g / day, if taking into account the disease required higher dose (heavier depression), can immediately be 150 mg 1r/dobu, then the daily dose can be increase of 37.5 -75 mg every 2 or 3 days with intervals of 2 weeks or more but not less than 4 days to achieve the desired therapeutic effect; recommended MDD - 225 mg for vertical integration depression, or 350 mg in severe depression, after achieve the desired therapeutic effect dose, depending on the efficacy and tolerance can be gradually reduced to the minimum effective level; episode of depression treatment should last at least 6 months for maintenance therapy and therapy to prevent recurrences or new episodes of depression, usually by the same dose have proved effective in normal episode of depression, the doctor should regularly, at least 1 time in 3 months, control effectiveness of long-term therapy, a sudden cessation of therapy, especially after high doses of the drug can cause symptoms cancellation, and therefore recommended before discontinuation vertical integration the drug gradually reduce its dose. Pharmacotherapeutic group: N06AX11 - antidepressants. solid, oral solution 30 mg, 60 mg. Selective inhibitors of reverse neuronal capture of serotonin. Method of production of drugs: cap. Side effects and complications in the use of drugs: tachycardia, hypertension, vasodilatation; Hypotension / orthostatic hypotension, loss of consciousness, arrhythmia, tachycardia, hemorrhage into the skin and mucous membranes; increase in bleeding time, hemorrhage, thrombocytopenia, dizziness, dry mouth, insomnia, anxiety, drowsiness; unusual dreams, agitation, vertical integration confusion, Modified increased muscle tone, tremor, violation vision and accommodation, midriaz, noise and tinnitus, respiratory failure, yawn, constipation, nausea, decreased appetite, vomiting, diarrhea, bruxism, the reverse increase Total Iron Binding Capacity hepatic enzymes, vertical integration bleeding; anorhazmiya, erectile dysfunction, ejaculation and orgasm violation, increased urination, decreased libido, menstrual irregularities, sweating, skin rash and itching, arthralgia, myalgia, increase in the level of serum cholesterol, increasing or decreasing mass body. The daily dose is best taken at a time at night, given vertical integration possible hypnotic effect; positive outcomes are found within the first 2-4 weeks of therapy, if over the next 2-4 weeks is observed positive effect, treatment should be stopped. stage MI, the violation of intracardiac conduction expressed liver and kidneys; zakrytokutova vertical integration delay the outflow vertical integration urine, simultaneous inhibition of MAO; g of alcohol poisoning, hypnotics, psychotropic substances. Contraindications to the use of drugs: hypersensitivity to any of the ingredients, the simultaneous application of any Groups antidepressant MAO inhibitors, and the period within 14 days of irreversible MAO inhibitors, after cancel venlafaksynu should wait at least 7 days before receiving MAO inhibitors, severe kidney disease and liver (Glomerular filtration rate less than 10 ml / min, protrombinovanyy time more than 18 seconds), severe heart disease (heart failure, coronary artery disease, ECG changes), violation of electrolyte balance, hypertension, children under 18 years period pregnancy and lactation. 25 mg, 50 mg. Dosing and Administration of drugs: dosage Exploratory Laparotomy choose individually change due to changes on the patient and his reaction to medication, and after reduction of symptoms can reduce the dose of the drug, and if at that again patient's condition worsened, the drug dose should be increased to the initial level, the daily recommended dose for infusion of - 25 - 100 mg infusion duration - vertical integration - 2 hours when entering a higher dose-75 - 150 mg - playing Infusion - 2 - 3 hours, with a clear dynamic of symptoms (within 1 - 2 weeks) - go to the appointment of the drug internally. Pharmacotherapeutic group: N06AX03 - antidepressants. The main pharmaco-therapeutic action: selectively inhibits reuptake of norepinephrine and serotonin, has no affinity with M-holinoretseptoramy, a-blockers, histamine H1-receptors, D1-and D2-dopaminergic, benzodiazepine and opioid receptors, vertical integration to the selective mechanism of action is achieved by a pronounced therapeutic effect, the maximum safety in treating depression, abnormal leveled, depressive mood, emotional normalized field, improving and accelerating the processes of thinking, increased focus with depression. The main pharmaco-therapeutic effects: belongs to the group-piperazyno azepinovyh compounds and different from the tricyclic antidepressants (TTSA) in the chemical structure of the missing side-chain specific for TTSA, which is responsible for their anticholinergic activity, raises the central noradrenerhichnu neyrotransmisiyu by ?2-blockade and autoretseptornoyi inhibition of reuptake of norepinephrine, found vertical integration interaction with serotonin receptors in CNS; antidepressant effect similar to the effect of other modern antidepressants, has anxiolytic effect, which is important in treating patients with depression combined with anxiety, sedative effects associated with exposure to mianserynu alpha 1-adrenoreceptors and N-1-histamine receptors, provides an opportunity to apply for treatment of sleep disorders in the Depression, when applying for therapeutic doses, has practically no anticholinergic activity and thus influence the CCC, with an overdose vertical integration less cardiotoxic effects compared with TTSA, shows no interaction with sympatomimetychnymy and hypotensive drugs, action which is related to exposure to beta-Adrenoceptors - betanidyn or alpha-Adrenoceptors - klonidyn or metyldopa. Method of production of drugs: Table., Coated tablets, 30 mg. Side effects and Induction Of Labor in the use of drugs: early treatment - drowsiness, which subsequently passes; vertical integration body, increasing enzyme pechinkovh, swelling, arterial hypotension, rash, arthralgia, convulsions; hiperkineziya; neuroleptic malignant c-m hypomania, granulocytopenia, bradycardia. Indications for use drugs: depressive states of here severity.